Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | HBB | P68871 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | AGXT | P21549 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | PLG | P00747 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | CTSG | P08311 | 1/20 | 0.41 |
| ▸ | CMA1 | P23946 | 1/20 | 0.41 |
| ▸ | CTRC | Q99895 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL860065 | 0.79 | ALDH1A1 (0.56) | ALDH1A1TSHRALOX15KDM4EHBB | |
| SCHEMBL5696335 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TSHRALOX15KDM4EHBB | |
| SCHEMBL23788144 | 0.78 | ALDH1A1 (0.62) | ALDH1A1TSHRALOX15KDM4EHBB | |
| SCHEMBL4911548 | 0.76 | IDO1 (0.48) | ALDH1A1TSHRALOX15KDM4EHBB | |
| SCHEMBL8142544 | 0.75 | ALDH1A1 (0.48) | ALDH1A1TSHRALOX15KDM4EHBB | |
| SCHEMBL399970 | 0.75 | MAPK14 (0.52) | ALDH1A1TSHRALOX15KDM4EKMT2A | |
| SCHEMBL13386604 | 0.74 | ALDH1A1 (0.55) | ALDH1A1TSHRALOX15IDO1 | |
| SCHEMBL5225296 | 0.74 | MGLL (0.50) | ALDH1A1TSHRALOX15IDO1AGXT | |
| SCHEMBL8151931 | 0.74 | ALDH1A1 (0.50) | ALDH1A1TSHRALOX15KDM4EHBB | |
| SCHEMBL24120672 | 0.74 | ALDH1A1 (0.50) | ALDH1A1TSHRALOX15KDM4EHBB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1090312-B1 | Method for photopolymerizing a monomer mixture to form a lens | BAUSCH & LOMB (US) | 2010-06-02 | — | — | EP | disclosed |
| EP-1459804-B1 | CATALYSTS COMPRISING CYCLIC ACYLUREA COMPOUNDS AND OXIDATION AND NITRATION REACTIONS OF ORGANIC COMPOUNDS IN THE PRESENCE OF THE SAME | DAICEL CHEM (JP) | 2010-06-02 | — | — | EP | disclosed |
| US-7288649-B2 | Catalyst comprising cyclic acylurea compound and process for producing organic compounds using the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-10-30 | — | — | US | disclosed |
| US-20060241293-A1 | Process for production n,n',n\"- trisubstituted isocyanuric acids | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-10-26 | — | — | US | disclosed |
| US-7091342-B2 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-08-15 | — | — | US | disclosed |
| EP-1666470-A1 | PROCESS FOR PRODUCTION OF N,N';N''-TRISUBSTITUTED ISOCYANURIC ACIDS | Daicel Chemical Industries, Ltd. (JP) | 2006-06-07 | — | — | EP | disclosed |
| US-20060030716-A1 | Catalyst comprising cyclic acylurea compound and process for producing organic compounds using the catalyst | ISHII YASUTAKA | 2006-02-09 | — | — | US | disclosed |
| US-20050020439-A1 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2005-01-27 | — | — | US | disclosed |
| EP-1459804-A1 | CATALYSTS COMPRISING CYCLIC ACYLUREA COMPOUNDS AND PROCESSES FOR PRODUCTION OF ORGANIC COMPOUNDS WITH THE SAME | Daicel Chemical Industries, Ltd. (JP) | 2004-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060030716-A1 | Catalyst comprising cyclic acylurea compound and process for producing organic compounds using the catalyst | MOGAT2, HAT1, ACOX1 | ALDH1A1 261/4885TSHR 1875/4885ALOX15 223/4885 |
| US-20060241293-A1 | Process for production n,n',n\"- trisubstituted isocyanuric acids | NANS, NOS2, FASN | ALDH1A1 618/4885TSHR 3872/4885ALOX15 1020/4885 |
| US-20050020439-A1 | Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same | MOGAT2, ACSS2, ACOX1 | ALDH1A1 258/4885TSHR 1846/4885ALOX15 241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.